Pharma Focus Asia
KP - Choose our fully recyclable blister films

New Exo-PDAC Assay Discovered for Early Detection of Pancreatic Ductal Adenocarcinoma (PDAC)

Biological Dynamics, Inc discovered new Exo-PDAC, liquid biopsy assay for the early detection of pancreatic ductal adenocarcinoma (PDAC) in high-risk adults.

Globally, pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal forms of cancer.

Exo-PDAC is the first assay using novel alternating current electrokinetic-based technology for early disease detection such as cancer, Alzheimer’s disease, and infectious diseases.

Exo-PDAC requires a small amount of blood from patients to analyse minimal sample preparation or processing.

By 2040, PDAC is expected to be the second common cancer leading to deaths due to the fact that the disease is asymptomatic in its initial stages. Patients undergo diagnosis during advanced stages of disease progression when treatments are limited. Detection of PDAC biomarkers at an early stage would help patients in further disease progression or metastasizes. However, this requires high degree of sensitivity and specificity where conventional laboratory testing methods lack. Early pancreatic cancer detection may save life of many individuals.  

U.S. Food and Drug Administration (FDA) grants breakthrough device designation for Exo-PDAC, early-stage pancreatic cancer detection test.

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Is your drug program on trackMasterControl - Manufacturing demoMasterControl - QMS demoThermo Fisher Scientific - Rapid Mycoplasma TestingThermoFisher Scientific - Save costs on your downstream process todayThermo Fisher Scientific - PeptonesMerck - Mobius® products5th Annual Pharma Manufacturing and Automation Convention 2023DUPHAT 202410TH ANNUAL GCC PHARMACY CONGRESS 202314th Annual Emirates Cardiac Society Conference 2023The International Hand & Wrist Congress 2023LabAsia 2023Pharma & Patient USA 2023Pharma Customer Engagement Europe 2023CHEMICAL INDONESIA 2024INALAB 2024